Derek Baird, Ben Squires, Marie-Eve Nault-Cloutier, Lucy Jenkins, William Kearney
January 24, 2026
Apax to Sell Azelis to EQT VIII Fund

1 min
AI-made summary
- Simpson Thacher is advising funds managed by Apax Partners on the sale of Azelis to the EQT VIII fund and the Public Sector Pension Investment Board
- The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the fourth quarter of 2018
- Financial terms were not disclosed
- Azelis is a global distributor of specialty chemicals and food ingredients, operating in over 40 countries and serving more than 43,000 customers.
Simpson Thacher is representing funds advised by Apax Partners in connection with the sale of Azelis to the EQT VIII fund and the Public Sector Pension Investment Board. The transaction is subject to customary closing conditions, including receipt of regulatory approvals, and is expected to close in the fourth quarter of 2018. The financial terms of the transaction were not announced.~~The Firm previously represented Apax on the acquisition of Azelis, including related European debt financing, and Azelis in connection with the significant add-on acquisition of Koda, including a refinancing of its debt with U.S. debt financing. Both transactions occurred in 2015.~~Azelis is a global distributor of specialty chemicals and food ingredients with a global presence in more than 40 countries. Azelis provides a diverse range of products and innovative services to more than 43,000 customers and 2,000 principals.
The Simpson Thacher team includes Derek Baird, Ben Squires and Marie-Eve Nault-Cloutier (M&A); Lucy Jenkins (Banking and Credit); and William Kearney (Antitrust).
Article Author
Derek Baird, Ben Squires, Marie-Eve Nault-Cloutier, Lucy Jenkins, William Kearney
The Sponsor
